Identification of odontogenic ameloblast associated as a novel target gene of the Wnt/β-catenin signaling pathway.


Journal

Cancer science
ISSN: 1349-7006
Titre abrégé: Cancer Sci
Pays: England
ID NLM: 101168776

Informations de publication

Date de publication:
Mar 2023
Historique:
revised: 31 10 2022
received: 28 06 2022
accepted: 09 11 2022
pubmed: 17 11 2022
medline: 8 3 2023
entrez: 16 11 2022
Statut: ppublish

Résumé

The Wnt/β-catenin signaling pathway plays a key role in development and carcinogenesis. Although some target genes of this signaling have been identified in various tissues and neoplasms, the comprehensive understanding of the target genes and their roles in the development of human cancer, including hepatoma and colorectal cancer remain to be fully elucidated. In this study, we searched for genes regulated by the Wnt signaling in liver cancer using HuH-7 hepatoma cells. A comparison of the expression profiles between cells expressing an active form of mutant β-catenin and cells expressing enhanced green fluorescent protein (EGFP) identified seven genes upregulated by the mutant β-catenin gene (CTNNB1). Among the seven genes, we focused in this study on ODAM, odontogenic, ameloblast associated, as a novel target gene. Interestingly, its expression was frequently upregulated in hepatocellular carcinoma, colorectal adenocarcinoma, and hepatoblastoma. We additionally identified a distant enhancer region that was associated with the β-catenin/TCF7L2 complex. Further analyses revealed that ODAM plays an important role in the regulation of the cell cycle, DNA synthesis, and cell proliferation. These data may be useful for clarification of the main molecular mechanism(s) underlying these cancers.

Identifiants

pubmed: 36382598
doi: 10.1111/cas.15657
pmc: PMC9986071
doi:

Substances chimiques

beta Catenin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

948-960

Informations de copyright

© 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

Références

Hepatology. 2003 Sep;38(3):560-6
pubmed: 12939582
Odontology. 2017 Jul;105(3):329-337
pubmed: 27807653
Nature. 1999 Apr 1;398(6726):422-6
pubmed: 10201372
Biotechnol Bioeng. 2017 Dec;114(12):2868-2882
pubmed: 28755500
Nature. 1996 Aug 15;382(6592):638-42
pubmed: 8757136
Cell Biochem Funct. 2015 Oct;33(7):451-61
pubmed: 26358398
Am J Med Genet. 1992 Aug 1;43(6):1023-5
pubmed: 1329510
Cell. 1996 Aug 9;86(3):391-9
pubmed: 8756721
Hepatology. 2017 Nov;66(5):1502-1518
pubmed: 28498607
Cells Tissues Organs. 2011;194(2-4):108-12
pubmed: 21576905
Nat Genet. 2020 Sep;52(9):919-930
pubmed: 32719515
Biomed Pharmacother. 2016 Dec;84:601-607
pubmed: 27694004
Eur J Oral Sci. 2007 Apr;115(2):153-60
pubmed: 17451507
Inflamm Res. 2022 Jan;71(1):119-129
pubmed: 34787682
PLoS One. 2014 Jan 22;9(1):e86582
pubmed: 24466159
Cancer Sci. 2023 Mar;114(3):948-960
pubmed: 36382598
Neoplasia. 2007 Nov;9(11):951-9
pubmed: 18030363
BMC Cancer. 2013 May 07;13:227
pubmed: 23648148
BMC Cancer. 2021 Oct 29;21(1):1156
pubmed: 34711185
J Pediatr. 2005 Aug;147(2):263-6
pubmed: 16126064
J Oral Pathol Med. 2012 Mar;41(3):272-80
pubmed: 21936873
Int J Oncol. 2005 Dec;27(6):1483-7
pubmed: 16273202
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1193-8
pubmed: 19144919
Oral Dis. 2007 Jul;13(4):360-5
pubmed: 17577321
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14973-8
pubmed: 11752446
J Biol Chem. 2002 Sep 6;277(36):33398-410
pubmed: 12052822
Am Surg. 2009 Sep;75(9):769-75; discussion 775
pubmed: 19774947
Development. 2009 Jun;136(11):1939-49
pubmed: 19429790
Nat Genet. 2002 Mar;30(3):290-4
pubmed: 11850621
Nat Commun. 2013;4:2610
pubmed: 24162018
Cell Cycle. 2018;17(19-20):2386-2397
pubmed: 30328366
Lancet Oncol. 2013 Aug;14(9):834-42
pubmed: 23831416
EMBO J. 2006 Jun 21;25(12):2735-45
pubmed: 16710294
J Cell Biochem. 2008 Feb 15;103(3):941-56
pubmed: 17647262
Cancer Sci. 2011 Aug;102(8):1486-92
pubmed: 21535316
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18627-32
pubmed: 17121988
Nature. 2007 Oct 25;449(7165):1003-7
pubmed: 17934449
Nat Genet. 2015 May;47(5):505-511
pubmed: 25822088
Med Oral Patol Oral Cir Bucal. 2005 Nov-Dec;10(5):402-9
pubmed: 16264375
J Periodontal Res. 2014 Dec;49(6):751-9
pubmed: 24410666
Nat Commun. 2021 Sep 20;12(1):5423
pubmed: 34538872
Breast Cancer (Auckl). 2011;5:73-85
pubmed: 21603257
Oncotarget. 2017 Oct 26;8(59):100176-100186
pubmed: 29245969
Mol Cell Biol. 2007 Aug;27(15):5430-44
pubmed: 17515607
Cancer Res. 1992 Jul 15;52(14):4055-7
pubmed: 1319838
Dev Dyn. 2010 Jan;239(1):140-7
pubmed: 19530172
Science. 1998 Sep 4;281(5382):1509-12
pubmed: 9727977
Nat Protoc. 2007;2(7):1722-33
pubmed: 17641637
Oncogene. 2010 Sep 9;29(36):5019-31
pubmed: 20581860
Mol Med. 2008 May-Jun;14(5-6):318-26
pubmed: 18472969
Orphanet J Rare Dis. 2009 Oct 12;4:22
pubmed: 19822006
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679

Auteurs

Kiyoshi Yamaguchi (K)

Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Chiaki Horie (C)

Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Kiyoko Takane (K)

Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Tsuneo Ikenoue (T)

Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Saya Nakagawa (S)

Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Yumiko Isobe (Y)

Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Yasunori Ota (Y)

Department of Pathology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Tetsuo Ushiku (T)

Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Mariko Tanaka (M)

Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Jun Fujishiro (J)

Department of Pediatric Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Noriko Hoshino (N)

Department of Pediatric Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Atsuhiro Arisue (A)

Department of Surgery, Iwate Medical University School of Medicine, Yahaba, Japan.

Satoshi Nishizuka (S)

Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Japan.

Susumu Aikou (S)

Division of Frontier Surgery, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Dai Shida (D)

Division of Frontier Surgery, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Yoichi Furukawa (Y)

Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH